FRNRX | SEPCX | FRNRX / SEPCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 22 years | - |
Gain YTD | 4.739 | 5.027 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 323M | 1.17M | 27,583% |
Annual Yield % from dividends | 1.83 | 0.00 | - |
Returns for 1 year | 8.10 | -0.86 | -945% |
Returns for 3 years | 26.71 | 10.77 | 248% |
Returns for 5 years | 63.02 | 36.14 | 174% |
Returns for 10 years | 8.75 | -7.18 | -122% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VGWIX | 22.04 | 0.02 | +0.09% |
Vanguard Global Wellesley Income Inv | |||
FIJYX | 30.44 | -0.05 | -0.16% |
Fidelity Advisor Biotechnology Z | |||
ALCBX | 12.38 | -0.15 | -1.20% |
ALPS/Smith Balanced Opportunity C | |||
HMCRX | 14.52 | -0.32 | -2.16% |
Harbor Mid Cap Retirement | |||
TIRTX | 28.64 | -0.68 | -2.32% |
Nuveen Large Cap Growth A |